Patient-Reported Outcomes for Irritable Bowel Syndrome Are Associated With Patients' Severity Ratings of Gastrointestinal Symptoms and Psychological Factors
Keywords: نرم افزار; Outcome Assessment; Questionnaires; FDA; Drug Approval; Labelling Claims; Symptom Severity; Clinical Trials; AS; anxiety sensitivity; FDA; Food and Drug Administration; GI; gastrointestinal; IBS; irritable bowel syndrome; IBS-SSS; Irritable Bowel Syndrome